Diabetes 51:1629-1634, 2002
© 2002 by the American Diabetes Association, Inc.
5' Flanking Variants of Resistin Are Associated With Obesity
James C. Engert1,
Marie-Claude Vohl2,3,
Scott M. Williams1,4,
Pierre Lepage1,
J C. Loredo-Osti5,
Janet Faith1,
Carole Doré1,
Yannick Renaud1,
Noël P. Burtt6,
Amélie Villeneuve1,
Joel N. Hirschhorn6,7,8,
David Altshuler6,7,9,
Leif C. Groop10,
Jean-Pierre Després2,3,11,
Daniel Gaudet12, and
Thomas J. Hudson1,5,6
1 Montreal Genome Centre, McGill University Health Centre Research Institute, Montréal, Canada
2 Lipid Research Center, CHUQ Pavillion CHUL, Québec, Canada
3 Department of Food Sciences and Nutrition, Laval University, Québec, Canada
4 Department of Microbiology, Meharry Medical College, Nashville, Tennessee
5 Department of Human Genetics, McGill University, Montréal, Canada
6 Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research, Cambridge, Massachusetts
7 Department of Genetics, Harvard Medical School, Boston, Massachusetts
8 Divisions of Genetics and Endocrinology, Childrens Hospital, Boston, Massachusetts
9 Department of Molecular Biology and Diabetes Unit, Massachusetts General Hospital, Boston, Massachusetts
10 Department of Endocrinology, Wallenberg Laboratory, Malmö University Hospital, University of Lund, Malmö, Sweden
11 Quebec Heart Institute, Laval Hospital Research Center, Sainte-Foy, Canada
12 Dyslipidemia, Diabetes and Atherosclerosis Group and Community Genomics Research Center, CHUM, Université de Montréal and Complexe Hospitalier de la Sagamie, Chicoutimi, Canada
Diabetes and obesity have long been known to be related. The recently characterized adipocyte hormone resistin (also called FIZZ3/ADSF) has been implicated as a molecular link between impaired glucose tolerance (IGT) and obesity in mice. A search for sequence variants at the human resistin locus identified nine single-nucleotide polymorphisms (SNPs) but no coding variants. An investigation into the association of these SNPs with diabetes and obesity revealed two 5' flanking variants (g.-537 and g.-420), in strong linkage disequilibrium, that are associated with BMI. In nondiabetic individuals from the Quebec City area and the Saguenay-Lac-St-Jean region of Quebec, the g.-537 mutation (allelic frequency = 0.04) was significantly associated with an increase in BMI (P = 0.03 and P = 0.01, respectively). When the data from these two populations were combined and adjusted for age and sex, both the g.-537 (odds ratio [OR] 2.72, 95% CI 1.285.81) and the g.-420 variants (1.58, 1.062.35) were associated with an increased risk for a BMI 30 kg/m2. In contrast, in case/control and family-based study populations from Scandinavia, we saw no effect on BMI with either of these promoter variants. No association was seen with diabetes in any of the population samples.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Ochi, H. Osawa, Y. Hirota, K. Hara, Y. Tabara, Y. Tokuyama, I. Shimizu, A. Kanatsuka, Y. Fujii, J. Ohashi, et al.
Frequency of the G/G Genotype of Resistin Single Nucleotide Polymorphism at 420 Appears to Be Increased in Younger-Onset Type 2 Diabetes
Diabetes,
November 1, 2007;
56(11):
2834 - 2838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-H. Chen, M.-J. Lee, H.-H. Chang, P.-F. Hung, and Y.-H. Kao
17{beta}-Estradiol Stimulates Resistin Gene Expression in 3T3-L1 Adipocytes via the Estrogen Receptor, Extracellularly Regulated Kinase, and CCAAT/Enhancer Binding Protein-{alpha} Pathways
Endocrinology,
September 1, 2006;
147(9):
4496 - 4504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Menzaghi, A. Coco, L. Salvemini, R. Thompson, S. De Cosmo, A. Doria, and V. Trischitta
Heritability of Serum Resistin and Its Genetic Correlation with Insulin Resistance-Related Features in Nondiabetic Caucasians
J. Clin. Endocrinol. Metab.,
July 1, 2006;
91(7):
2792 - 2795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-S. Liu, Y.-H. Chen, P.-F. Hung, and Y.-H. Kao
Inhibitory effect of green tea (-)-epigallocatechin gallate on resistin gene expression in 3T3-L1 adipocytes depends on the ERK pathway
Am J Physiol Endocrinol Metab,
February 1, 2006;
290(2):
E273 - E281.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Graveleau, V. G. Zaha, A. Mohajer, R. R. Banerjee, N. Dudley-Rucker, C. M. Steppan, M. W. Rajala, P. E. Scherer, R. S. Ahima, M. A. Lazar, et al.
Mouse and Human Resistins Impair Glucose Transport in Primary Mouse Cardiomyocytes, and Oligomerization Is Required for This Biological Action
J. Biol. Chem.,
September 9, 2005;
280(36):
31679 - 31685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-H. Chen, P.-F. Hung, and Y.-H. Kao
IGF-I downregulates resistin gene expression and protein secretion
Am J Physiol Endocrinol Metab,
May 1, 2005;
288(5):
E1019 - E1027.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Poon, C. Laprise, M. Lemire, A. Montpetit, D. Sinnett, E. Schurr, and T. J. Hudson
Association of Vitamin D Receptor Genetic Variants with Susceptibility to Asthma and Atopy
Am. J. Respir. Crit. Care Med.,
November 1, 2004;
170(9):
967 - 973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-S. Youn, K.-Y. Yu, H. J. Park, N. S. Lee, S. S. Min, M. Y. Youn, Y. M. Cho, Y. J. Park, S. Y. Kim, H. K. Lee, et al.
Plasma Resistin Concentrations Measured by Enzyme-Linked Immunosorbent Assay Using a Newly Developed Monoclonal Antibody Are Elevated in Individuals with Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab.,
January 1, 2004;
89(1):
150 - 156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. McTernan, F. M. Fisher, G. Valsamakis, R. Chetty, A. Harte, C. L. McTernan, P. M. S. Clark, S. A. Smith, A. H. Barnett, and S. Kumar
Resistin and Type 2 Diabetes: Regulation of Resistin Expression by Insulin and Rosiglitazone and the Effects of Recombinant Resistin on Lipid and Glucose Metabolism in Human Differentiated Adipocytes
J. Clin. Endocrinol. Metab.,
December 1, 2003;
88(12):
6098 - 6106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Lee, J. L. Chan, N. Yiannakouris, M. Kontogianni, E. Estrada, R. Seip, C. Orlova, and C. S. Mantzoros
Circulating Resistin Levels Are Not Associated with Obesity or Insulin Resistance in Humans and Are Not Regulated by Fasting or Leptin Administration: Cross-Sectional and Interventional Studies in Normal, Insulin-Resistant, and Diabetic Subjects
J. Clin. Endocrinol. Metab.,
October 1, 2003;
88(10):
4848 - 4856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Smith, F. Bai, C. Charbonneau, L. Janderova, and G. Argyropoulos
A Promoter Genotype and Oxidative Stress Potentially Link Resistin to Human Insulin Resistance
Diabetes,
July 1, 2003;
52(7):
1611 - 1618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Chen and B. L. G. Nyomba
Glucose Intolerance and Resistin Expression in Rat Offspring Exposed to Ethanol in Utero: Modulation by Postnatal High-Fat Diet
Endocrinology,
February 1, 2003;
144(2):
500 - 508.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|